|
FY2023
12 months to Mar 30, 2024
|
FY2022
12 months to Apr 1, 2023
|
FY2021
12 months to Apr 2, 2022
|
FY2020
12 months to Apr 3, 2021
|
FY2019
12 months to Mar 28, 2020
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales (excluding depreciation and amortization) | |||||
| Gross profit | |||||
| Selling, general, and administrative expenses (excluding depreciation and amortization) | |||||
| Impairment charges | |||||
| Stock-based compensation | |||||
| Pre-opening costs | |||||
| Depreciation and amortization | |||||
| Other expenses | |||||
| Loss on disposal of assets | |||||
| (Loss) income from operations | |||||
| Interest expense, net | |||||
| (Loss) income before taxes | |||||
| (Benefit) provision for income taxes | |||||
| Net (loss) income | |||||
| Net (loss) income per common share - basic (in dollars per share) | |||||
| Net (loss) income per common share - diluted (in dollars per share) | |||||
| Weighted-average common shares - basic (in shares) | |||||
| Weighted-average common shares - diluted (in shares) | |||||
Loading...